Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
复制标题
骨髓源性抑制细胞:抗癌免疫治疗的新兴靶点
DOI:
10.1186/s12943-022-01657-y
复制
发表时间:
2022-09-26
期刊:
影响因子:
37.3
通讯作者:
Wu, Kongming
中科院分区:
文献类型:
--
作者:
Wu, Yuze;Yi, Ming;Niu, Mengke;Mei, Qi;Wu, Kongming
关键词:
The clinical responses observed following treatment with immune checkpoint inhibitors (ICIs) support immunotherapy as a potential anticancer treatment. However, a large proportion of patients cannot benefit from it due to resistance or relapse, which is most likely attributable to the multiple immunosuppressive cells in the tumor microenvironment (TME). Myeloid-derived suppressor cells (MDSCs), a heterogeneous array of pathologically activated immature cells, are a chief component of immunosuppressive networks. These cells potently suppress T-cell activity and thus contribute to the immune escape of malignant tumors. New findings indicate that targeting MDSCs might be an alternative and promising target for immunotherapy, reshaping the immunosuppressive microenvironment and enhancing the efficacy of cancer immunotherapy. In this review, we focus primarily on the classification and inhibitory function of MDSCs and the crosstalk between MDSCs and other myeloid cells. We also briefly summarize the latest approaches to therapies targeting MDSCs.
登录
查看更多内容
影响因子:
17.1
作者:
Chung, Andrew W.;Anand, Kartik;Chang, Jenny C.
通讯作者:
Chang, Jenny C.
影响因子:
4.4
作者:
Almand, B;Clark, JI;Gabrilovich, DI
通讯作者:
Gabrilovich, DI
影响因子:
6.6
作者:
Angell, Trevor E.;Lechner, Melissa G.;Epstein, Alan L.
通讯作者:
Epstein, Alan L.
影响因子:
11.2
作者:
Chang AL;Miska J;Wainwright DA;Dey M;Rivetta CV;Yu D;Kanojia D;Pituch KC;Qiao J;Pytel P;Han Y;Wu M;Zhang L;Horbinski CM;Ahmed AU;Lesniak MS
通讯作者:
Lesniak MS
影响因子:
11.2
作者:
Bunt, Stephanie K.;Yang, Linglin;Ostrand-Rosenberg, Suzanne
通讯作者:
Ostrand-Rosenberg, Suzanne